Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France.
Fiche publication
Date publication
avril 2022
Journal
JAMA network open
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles, Dr JOUANNAUD Christelle
Tous les auteurs :
Charles C, Bardet A, Larive A, Gorwood P, Ramoz N, Thomas E, Viari A, Rousseau-Tsangaris M, Dumas A, Menvielle G, Everhard S, Martin AL, Gbenou SY, Havas J, El-Mouhebb M, Di Meglio A, André F, Pistilli B, Coutant C, Cottu P, Mérimèche A, Lerebours F, Tredan O, Vanlemmens L, Jouannaud C, Levy C, Vaz-Luis I, Michiels S, Dauchy S
Lien Pubmed
Résumé
Breast cancer (BC) diagnosis and treatment expose patients to a 5-fold higher risk of depression compared with the general population, with an estimated prevalence of 10% to 25%. A depressive episode in patients with BC has implications for the tolerance of and adherence to treatment, impairing quality of life and reducing life expectancy.
Référence
JAMA Netw Open. 2022 Apr 1;5(4):e225118